93888-6 |
Methane/Expired gas^30M post dose carbohydrate |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose carbohydrate |
|
ADD |
DefinitionDescription |
|
|
ppm |
|
|
|
|
|
|
CHAL |
|
93888-6 |
|
|
|
|
Observation |
|
|
|
0 |
Breath methane 30M p carb |
|
|
|
|
|
30M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ppm] |
|
|
|
0 |
93889-4 |
Methane/Expired gas^15M post dose carbohydrate |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Methane/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose carbohydrate |
|
ADD |
DefinitionDescription |
|
|
ppm |
|
|
|
|
|
|
CHAL |
|
93889-4 |
|
|
|
|
Observation |
|
|
|
0 |
Breath methane 15M p carb |
|
|
|
|
|
15M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ppm] |
|
|
|
0 |
9389-8 |
Pseudoephedrine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Pseudoephedrine [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
9389-8 |
|
|
|
|
Both |
|
|
|
0 |
Pseudoephedrine SerPl-mCnc |
|
|
|
Y |
|
Cenafed; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pseudoephed; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sudafed |
2.73 |
1.0i |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
93890-2 |
Methane/Expired gas^pre dose carbohydrate |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Methane/Expired gas [Volume Fraction] in Exhaled gas --pre dose carbohydrate |
|
ADD |
DefinitionDescription |
|
|
ppm |
|
|
|
|
|
|
CHAL |
|
93890-2 |
|
|
|
|
Observation |
|
|
|
0 |
Breath methane pre carb |
|
|
|
|
|
Before; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Percent; Point in time; pre carb; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ppm] |
|
|
|
0 |
93891-0 |
Methane/Expired gas^post dose carbohydrate |
VFr |
Exhl gas |
Pt |
Qn |
|
|
ACTIVE |
Methane/Expired gas [Volume Fraction] in Exhaled gas --post dose carbohydrate |
|
ADD |
DefinitionDescription |
|
|
ppm |
|
|
|
|
|
|
CHAL |
|
93891-0 |
|
|
|
|
Observation |
|
|
|
0 |
Breath methane p carb |
|
|
|
|
|
After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction |
2.67 |
2.67 |
|
|
|
|
|
|
|
[ppm] |
|
|
|
0 |
93892-8 |
Progress note |
Find |
{Setting} |
Pt |
Doc |
Addiction medicine |
|
ACTIVE |
Addiction medicine Progress note |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93892-8 |
|
Addiction medicine |
|
|
Both |
|
|
|
0 |
Addiction med Prog note |
|
|
|
|
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Substance abuse; Visit note |
2.73 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93893-6 |
Conference note |
Find |
{Setting} |
Pt |
Doc |
Orthopaedic surgery.team |
|
ACTIVE |
Orthopaedic surgery Team Conference note |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93893-6 |
|
Orthopaedic surgery.team |
|
|
Both |
|
|
|
0 |
Ortho surg Team Conf note |
|
|
|
|
|
Conf note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Ortho surg Team; Orthopedic; Orthopedic surgery; Point in time; Random; Surg; Visit note |
2.78 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93894-4 |
Conference note |
Find |
{Setting} |
Pt |
Doc |
Hematology.team |
|
ACTIVE |
Hematology Team Conference note |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93894-4 |
|
Hematology.team |
|
|
Both |
|
|
|
0 |
Hematology Team Conf note |
|
|
|
|
|
Conf note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology Team; notes; Point in time; Random; Visit note |
2.78 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93895-1 |
Conference note |
Find |
{Setting} |
Pt |
Doc |
Gynecologic oncology.team |
|
ACTIVE |
Gynecologic oncology Team Conference note |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93895-1 |
|
Gynecologic oncology.team |
|
|
Both |
|
|
|
0 |
Gyn onc Team Conf note |
|
|
|
|
|
Cancer; Conf note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn Onc; Gyn onc Team; notes; Point in time; Random; Visit note |
2.78 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93896-9 |
Note |
Find |
Telephone encounter |
Pt |
Doc |
Gynecologic oncology |
|
ACTIVE |
Gynecologic oncology Telephone encounter Note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93896-9 |
|
Gynecologic oncology |
|
|
Both |
|
|
|
0 |
Gyn Onc Phone Note |
|
|
|
|
|
Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn Onc; notes; Point in time; Random; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93897-7 |
Progress note |
Find |
{Setting} |
Pt |
Doc |
Maternal and fetal medicine |
|
ACTIVE |
Maternal and fetal medicine Progress note |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93897-7 |
|
Maternal and fetal medicine |
|
|
Both |
|
|
|
0 |
Mat fetal med Prog note |
|
|
|
|
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mat fetal med; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note |
2.73 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93898-5 |
Note |
Find |
Telephone encounter |
Pt |
Doc |
Family medicine |
|
ACTIVE |
Family medicine Telephone encounter Note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93898-5 |
|
Family medicine |
|
|
Both |
|
|
|
0 |
Fam Med Phone Note |
|
|
|
|
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Fam Med; Finding; Findings; notes; Point in time; Random; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93899-3 |
Letter |
Find |
{Setting} |
Pt |
Doc |
Psychiatry |
|
ACTIVE |
Psychiatry Letter |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93899-3 |
|
Psychiatry |
|
|
Both |
|
|
|
0 |
Psychiatric Letter |
|
|
|
|
|
DOC.ONT; Document; Finding; Findings; Point in time; Psychiatric; Random |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
939-9 |
Bombay Ab |
ACnc |
Ser |
Pt |
Ord |
Aggl RBC |
|
DEPRECATED |
Deprecated Bombay Ab |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
939-9 |
|
Aggl RBC |
|
|
|
|
|
|
0 |
Deprecated Bombay Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.36 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
9390-6 |
Pyridostigmine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Pyridostigmine [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
9390-6 |
|
|
|
|
Both |
|
|
|
0 |
Pyridostigmine SerPl-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mestinon; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0i |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
93900-9 |
Progress note |
Find |
{Setting} |
Pt |
Doc |
Healthcare navigator |
|
ACTIVE |
Healthcare navigator Progress note |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93900-9 |
|
Healthcare navigator |
|
|
Both |
|
|
|
0 |
Navigator Prog note |
|
|
|
|
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note |
2.73 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93901-7 |
Note |
Find |
Telephone encounter |
Pt |
Doc |
Healthcare navigator |
|
ACTIVE |
Healthcare navigator Telephone encounter Note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93901-7 |
|
Healthcare navigator |
|
|
Both |
|
|
|
0 |
Navigator Phone Note |
|
|
|
|
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93902-5 |
Plan of care note |
Find |
{Setting} |
Pt |
Doc |
Healthcare navigator |
|
ACTIVE |
Healthcare navigator Plan of care note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93902-5 |
|
Healthcare navigator |
|
|
Both |
|
|
|
0 |
Navigator Plan of care note |
|
|
|
|
|
Care plan; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Treatment plan; Visit note |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93903-3 |
Discharge summary note |
Find |
{Setting} |
Pt |
Doc |
Healthcare navigator |
|
ACTIVE |
Healthcare navigator Discharge summary |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93903-3 |
|
Healthcare navigator |
|
|
Both |
|
|
|
0 |
Navigator D/C sum |
|
|
|
|
|
D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note |
2.73 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93904-1 |
Transfusion reaction panel |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
Transfusion reaction panel |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.BLDBK |
|
93904-1 |
|
|
|
|
Order |
|
|
|
0 |
Transf React Pnl |
|
|
|
|
|
BLOOD BANK; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; React; Rxn; Transf React; Transf React Pnl; Tx |
2.79 |
2.67 |
|
Convenience group |
|
|
|
|
|
|
|
|
|
0 |
93905-8 |
ABO group^during infancy |
Type |
Bld |
Pt |
Nom |
|
|
ACTIVE |
ABO group [Type] in Blood--during infancy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
93905-8 |
|
|
|
|
Both |
|
|
|
0 |
ABO Group infant Bld |
|
|
|
|
|
ABO Gp^infant; Blood; BLOOD BANK; infant; Nominal; Point in time; Random; Typ; WB; Whole blood |
2.72 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93906-6 |
ABO & Rh group^during infancy |
Type |
Bld |
Pt |
Nom |
|
|
ACTIVE |
ABO and Rh group [Type] in Blood--during infancy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
93906-6 |
|
|
|
|
Both |
|
|
|
0 |
ABO + Rh infant Bld |
|
|
|
|
|
ABO + Rh; ABO group and Rh type; ABO+Rh Gp; ABO+Rh Gp^infant; Blood; BLOOD BANK; D phenotyping; D typing; infant; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood |
2.72 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93907-4 |
L little u 20 Ag |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
Lu 20 Ag [Presence] on Red Blood Cells |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
93907-4 |
|
|
|
|
Both |
|
|
|
0 |
Lu 20 Ag RBC Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; Erythrocytes; Left; Levo; Lu 20; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93908-2 |
A little u super little b Ag |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
Au sup(b) Ag [Presence] on Red Blood Cells |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
93908-2 |
|
|
|
|
Both |
|
|
|
0 |
Au sup(b) Ag RBC Ql |
|
|
|
|
|
A little u super little b; Antigen; Antigens; Au sup(b); Au^b Ag; Auberger; BLOOD BANK; Erythrocytes; LU19; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
93909-0 |
J little k3 Ag |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
Jk3 Ag [Presence] on Red Blood Cells |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
93909-0 |
|
|
|
|
Both |
|
|
|
0 |
Jk3 Ag RBC Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; Erythrocytes; Jk3; Jk3 Ag; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |